Genetics and Susceptibility to Malignant Hyperthermia
Kathryn Anderson-Pompa, RN, BSN, CCRN, April Foster, RN, BSN, CCRN, Lee Parker, RN, BA, CCRN, CEN, Lance Wilks, RN, BSN, CCRN, and Dennis J. Cheek, RN, PhD 
 
 
Learning Objectives - At the completion of this program, the learner will be able to:
Objective 1: Discuss how advances in the study of genomics will affect the practice of critical care nurses in the future
Objective 2: Describe how genetic mapping can predict susceptibility to malignant hyperthermia
Objective 3: Discuss the pharmacological triggers for malignant hyperthermia reactions
 
CE ID: C0862 Contact Hours: 1.5
Synergy Cat: A
Form Expires: 12/1/2010
 
Program Title and Description
Genetics and Susceptibility to Malignant Hyperthermia
Publication/Sponsor Information
Critical Care Nurse is an official publication of the American Association of Critical-Care Nurses (AACN), and copyright belongs to AACN. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording or by any information storage retrieval system without permission of AACN. For all permission requests, please contact the Copyright Clearance Center, Customer Service, 222 Rosewood Drive, Danvers, MA 01923. (978) 750-8400. The statements and opinions contained herein are solely those of individual contributors and not of the editors, AACN, or The InnoVision Group. The editors, AACN, and The InnoVision Group assume that articles emanating from a particular institution are submitted with the approval of the requisite authority, including all matters pertaining to human studies and patient privacy requirements.
 
 
Click on the title below to view
Genetics and Susceptibility to Malignant Hyperthermia
In order to read some of the CE content you will need to download the following FREE reader:
 
 
Take Test Return